CHRS

Coherus Oncology, Inc. - Common Stock (CHRS)

About Coherus Oncology, Inc. - Common Stock (CHRS)

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Details

Daily high

$1.37

Daily low

$1.30

Price at open

$1.35

52 Week High

$2.62

52 Week Low

$1.09

Market cap

208.6M

Dividend yield

Volume

493,219

Avg. volume

1.0M

P/E ratio

-1.32

Coherus Oncology, Inc. - Common Stock News